Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.4092
-0.02
(-5.49%)
USD |
OTCM |
May 29, 16:00
Reviva Pharmaceuticals Holdings EPS Diluted (Quarterly) : -0.4551 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.308 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.196M |
| Total Expenses (Quarterly) | 3.196M |
| Enterprise Value | -16.59M |
| Earnings Yield | -1.11K% |
| Normalized Earnings Yield | -1115.33 |